Le Fort III osteotomy

From WikiMD's WELLNESSPEDIA

File:LeFort3 Osteotomie.png
Diagram of a Le Fort III osteotomy

The Le Fort III osteotomy is a surgical procedure used to correct midface deformities. It is one of the three classic Le Fort osteotomies, which are named after the French surgeon René Le Fort, who described the fracture patterns in the early 20th century. The Le Fort III osteotomy involves the detachment and repositioning of the midface, including the zygomatic bone, maxilla, and the nasal bones, to correct congenital or acquired deformities.

Indications[edit]

The Le Fort III osteotomy is primarily indicated for patients with midface hypoplasia, which can occur in conditions such as Crouzon syndrome, Apert syndrome, and other craniofacial dysostoses. It is also used in cases of severe maxillary retrusion and in some instances of obstructive sleep apnea where the midface is underdeveloped.

Surgical Technique[edit]

The procedure involves making incisions in the oral cavity and sometimes on the face to access the bones of the midface. The surgeon then carefully separates the midface from the skull base, allowing it to be repositioned forward. This advancement can be stabilized using titanium plates and screws. In some cases, bone grafts may be used to fill gaps and ensure proper healing.

Postoperative Care[edit]

After a Le Fort III osteotomy, patients typically require a hospital stay for monitoring and pain management. Swelling and bruising are common, and patients may need to follow a soft diet for several weeks. Regular follow-up appointments are necessary to monitor healing and ensure that the bones are properly aligned.

Complications[edit]

As with any major surgery, there are potential complications associated with the Le Fort III osteotomy. These can include infection, bleeding, and adverse reactions to anesthesia. There is also a risk of nerve damage, which can lead to numbness or altered sensation in the face. Long-term complications may include relapse of the deformity or issues with occlusion.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.